Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Rising incidence of hepatocellular carcinoma in the United States.

El-Serag HB, Mason AC.

N Engl J Med. 1999 Mar 11;340(10):745-50.

2.

Risk factors for the rising rates of primary liver cancer in the United States.

El-Serag HB, Mason AC.

Arch Intern Med. 2000 Nov 27;160(21):3227-30.

PMID:
11088082
3.

The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update.

El-Serag HB, Davila JA, Petersen NJ, McGlynn KA.

Ann Intern Med. 2003 Nov 18;139(10):817-23. Erratum in: Ann Intern Med. 2004 Jan 20;140(2):151.

PMID:
14623619
4.

Geographic variation within the United States in the incidence of hepatocellular carcinoma.

Davila JA, Petersena NJ, Nelson HA, El-Serag HB.

J Clin Epidemiol. 2003 May;56(5):487-93.

PMID:
12812824
5.

Epidemiology of primary hepatic malignancies in U.S. children.

Darbari A, Sabin KM, Shapiro CN, Schwarz KB.

Hepatology. 2003 Sep;38(3):560-6.

PMID:
12939582
6.

Epidemiology of hepatocellular carcinoma in Hispanics in the United States.

El-Serag HB, Lau M, Eschbach K, Davila J, Goodwin J.

Arch Intern Med. 2007 Oct 8;167(18):1983-9.

PMID:
17923599
7.

Childhood cancer among Alaska Natives.

Lanier AP, Holck P, Ehrsam Day G, Key C.

Pediatrics. 2003 Nov;112(5):e396.

PMID:
14595083
8.
9.

Hepatocellular carcinoma - United States, 2001-2006.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 May 7;59(17):517-20.

10.

Mortality from hepatocellular and biliary cancers: changing epidemiological trends.

Nair S, Shiv Kumar K, Thuluvath PJ.

Am J Gastroenterol. 2002 Jan;97(1):167-71. Erratum in: Am J Gastroenterol 2002 May;97(5):1280. Shivakumar KS [corrected to Shiva Kumar K]. Am J Gastroenterol 2002 Aug;97(9):2484. Shiva Kumar K [corrected to Shiv Kumar K].

PMID:
11808943
11.

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

Altekruse SF, McGlynn KA, Reichman ME.

J Clin Oncol. 2009 Mar 20;27(9):1485-91. doi: 10.1200/JCO.2008.20.7753. Epub 2009 Feb 17.

12.

Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study.

Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB.

Gastroenterology. 2004 Nov;127(5):1372-80.

PMID:
15521006
13.
14.

Assessing changes in the impact of cancer on population survival without considering cause of death.

Brown BW, Brauner C, Levy LB.

J Natl Cancer Inst. 1997 Jan 1;89(1):58-65.

PMID:
8978407
15.

Trends in palatine tonsillar cancer incidence and mortality rates in the United States.

Golas SM.

Community Dent Oral Epidemiol. 2007 Apr;35(2):98-108.

PMID:
17331151
16.

Trends in prostate cancer mortality among black men and white men in the United States.

Chu KC, Tarone RE, Freeman HP.

Cancer. 2003 Mar 15;97(6):1507-16.

17.

Hepatocellular carcinoma: recent trends in the United States.

El-Serag HB.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S27-34. Review.

PMID:
15508094
18.

The impact of immigration on the increasing incidence of hepatocellular carcinoma in the United States.

Kulkarni K, Barcak E, El-Serag H, Goodgame R.

Aliment Pharmacol Ther. 2004 Aug 15;20(4):445-50.

19.

Epidemiology of hepatocellular carcinoma.

el-Serag HB.

Clin Liver Dis. 2001 Feb;5(1):87-107, vi. Review.

PMID:
11218921
20.

Risk-adjusted cancer-incidence rates (United States).

Merrill RM, Feuer EJ.

Cancer Causes Control. 1996 Sep;7(5):544-52.

PMID:
8877053

Supplemental Content

Support Center